APLMW vs. ATNFW, SXTPW, DRTSW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW
Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.
180 Life Sciences (NASDAQ:ATNFW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, community ranking, institutional ownership, valuation and dividends.
180 Life Sciences and Apollomics both received 0 outperform votes by MarketBeat users.
In the previous week, Apollomics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Apollomics and 1 mentions for 180 Life Sciences. Apollomics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.50 indicating that 180 Life Sciences is being referred to more favorably in the media.
Summary
180 Life Sciences and Apollomics tied by winning 1 of the 2 factors compared between the two stocks.
Get Apollomics News Delivered to You Automatically
Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
APLMW vs. The Competition
Apollomics Competitors List
Related Companies and Tools
